Analysis of gross deletions in the MEN1 gene in patients with multiple endocrine neoplasia type 1.

Analysis of gross deletions in the MEN1 gene in patients with multiple endocrine neoplasia type 1. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Analysis of gross deletions in the MEN1 gene in patients with multiple endocrine neoplasia type 1. Abstract Text:

Martina Owens,Sian Ellard,Bijay Vaidya,

BACKGROUND: Mutation analysis with direct DNA sequencing is commonly used for the molecular diagnosis of multiple endocrine neoplasia type 1 (MEN1). However, a significant number of patients, despite clinical features of MEN1, do not show MEN1 mutations on direct DNA sequencing. Some of these patients may have gross gene deletions not detected by direct DNA sequencing or mutations in the noncoding regions of the gene not examined routinely. OBJECTIVE: To determine the prevalence of gross deletions in MEN1 in a large cohort of MEN1 patients. PATIENTS AND METHODS: During 1997-2006, we screened MEN1 mutations by direct DNA sequencing in 368 probands referred to our diagnostic molecular genetic laboratory. Of these, 101 probands (23 familial, 78 sporadic) fulfilled the clinical criteria for MEN1 (presence of at least two of the parathyroid, pancreatic or pituitary tumours) but were negative for mutations on DNA sequencing. Their DNA samples were examined for gross deletions of one or more exons of MEN1 by using multiple ligation-dependent probe amplification (MLPA) and long-range polymerase chain reaction (PCR) amplification. We also sequenced the minimal promoter region of MEN1 for mutations in the familial cases. RESULTS: We identified a gross deletion involving exons 5 and 6 of MEN1 in one proband (prevalence rate 1%). The sequencing of the minimal promoter region in the familial cases revealed no mutations. CONCLUSION: Gross deletion in the MEN1 gene is an uncommon cause of MEN1 and should be tested for in patients with a high clinical suspicion but without mutations on direct DNA sequencing.

Analysis of gross deletions in the MEN1 gene in patients with multiple endocrine neoplasia type 1. Publishing Authors By Initials

M Owens,S Ellard,B Vaidya,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Analysis of gross deletions in the MEN1 gene in patients with multiple endocrine neoplasia type 1. Journal Published:

PUBLICATION TYPE: Research Support, Non-U.S. Gov

Journal: Clinical endocrinology

VOLUME: 68

Page Numbers: 350-4

Journal Abbreviation: Clin. Endocrinol. (Oxf)

ISSN: 1365-2265

DAY: 14

MONTH: 09

YEAR: 2007

Analysis of gross deletions in the MEN1 gene in patients with multiple endocrine neoplasia type 1. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 346653

Analysis of gross deletions in the MEN1 gene in patients with multiple endocrine neoplasia type 1. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Analysis of gross deletions in the MEN1 gene in patients with multiple endocrine neoplasia type 1. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Analysis of gross deletions in the MEN1 gene in patients with multiple endocrine neoplasia type 1.

AFFILIATION: Department of Molecular Genetics, Royal Devon and Exeter Hospital, Peninsula Medical School, Exeter, UK.

Country: England

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Clin Endocrinol (Oxf)

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Analysis of gross deletions in the MEN1 gene in patients with multiple endocrine neoplasia type 1 Related Publications

• A POINT IN FAVOUR OF PROFESSOR ARTHUR THOMSON'S THEORY OF THE PRODUCTION OF GLAUCOMA.
• Acute renal failure secondary to oxalosis in a recipient of a simultaneous kidney-pancreas transplant: was mycophenolate the cause?
• Analysis of gross deletions in the MEN1 gene in patients with multiple endocrine neoplasia type 1.
• Anti-phospholipid antibody-mediated rejection.
• Antidepressant treatments regulate matrix metalloproteinases-2 and -9 (MMP-2/MMP-9) and tissue inhibitors of the metalloproteinases (TIMPS 1-4) in the adult rat hippocampus.
• Atypical neural substrates of Embedded Figures Task performance in children with Autism Spectrum Disorder.
• Biomechanical analysis of differing pedicle screw insertion angles.
• Carpopedal spasm in an elderly man: an unusual presentation of coeliac disease.
• Clinical importance of anti-human leukocyte antigen-specific antibody concentration in performing calculated panel reactive antibody and virtual crossmatches.
• Cocirculation of and coinfections with hepatitis A virus subgenotypes IIIA and IB in patients from Pune, western India.
• Development of a real-time polymerase chain reaction assay for the quantification of Leishmania species and the monitoring of systemic distribution of the pathogen.
• Developmental differences in cognitive control of socio-affective processing.
• Early antiretroviral therapy: The pendulum shifts again.
• Effects of atypical anxiolytic N-phenyl-2-[1-[3-(2-pyridinylethynyl)benzoyl]-4-piperidine]acetamide (JNJ-5234801) on alcohol intake in alcohol-preferring P rats.
• Induction of autophagic cell death in Leishmania donovani by antimicrobial peptides.
• Influence of fluoride containing toothpaste on serum and urine fluoride levels in children.
• Mathematical modelling of radiotherapy strategies for early breast cancer.
• Method to test whether late extended letrozole, rather than self- selection, improves the outcome in patients with breast cancer who have completed 5 years of tamoxifen.
• Mitochondrial drug targets in apicomplexan parasites.
• Novel technologies for the discovery and quantitation of biomarkers of toxicity.
• Plasmodium vivax malaria in spite of atovaquone/proguanil (malarone) prophylaxis.
• Platelet Inhibition by Aspirin 81 and 325 mg/day in Men Versus Women Without Clinically Apparent Cardiovascular Disease.
• Platelet functional implications of glycoprotein Ibalpha polymorphisms in African Americans.
• Polymer platforms for drug delivery and biomedical imaging.
• Psychiatry Clerkship Objective Structured Clinical Examination is Here to Stay.
• Pyridine biodegradation in a novel rotating rope bioreactor.
• Racial differences of lipoprotein subclass distributions in postmenopausal women.
• Re: Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population.
• Stressor-specific regulation of distinct brain-derived neurotrophic factor transcripts and cyclic AMP response element-binding protein expression in the postnatal and adult rat hippocampus.
• Vitamin D and cancer.